Dataset Information


Reversal of MECP2 duplication syndrome using genetic rescue and antisense oligonucleotides [ASO time point 1]

ABSTRACT: MECP2 duplication syndrome, a childhood neurological disorder characterized by autism, intellectual disability, motor dysfunction, anxiety and epilepsy, is caused by a duplication on chromosome Xq28 spanning the MECP2 gene that results in doubling of MeCP2 levels. MECP2 overexpression in mice causes neurobehavioral and electroencephalographic defects similar to those of human patients, but the gross anatomy of the brain remains unaffected. We hypothesized that MECP2 duplication syndrome would be reversible and tested two methods to restore MeCP2 levels to normal: conditional genetic recombination and antisense oligonucleotide therapy. Both approaches rescued molecular, physiological and behavioral features of adult symptomatic mice. Antisense therapy also restored normal MeCP2 levels in lymphoblastoid cells from MECP2 duplication patients, in a dose-dependent manner. Our data indicate that antisense oligonucleotides could provide a viable therapeutic approach for human MECP2 duplication syndrome as well as other disorders involving copy number gains. Overall design: Hippocampal mRNA profiles of WT, MECP2-TG and MECP2-TG ASO-treated treated mice 4weeks after the initiation of the treatment, were generated by deep sequencing, in triplicate, using Illumina TruSeq.

INSTRUMENT(S): Illumina HiSeq 2000 (Mus musculus)

SUBMITTER: Yehezkel Sztainberg  

PROVIDER: GSE71233 | GEO | 2015-11-27



altmetric image


Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides.

Sztainberg Yehezkel Y   Chen Hong-mei HM   Swann John W JW   Hao Shuang S   Tang Bin B   Wu Zhenyu Z   Tang Jianrong J   Wan Ying-Wooi YW   Liu Zhandong Z   Rigo Frank F   Zoghbi Huda Y HY  

Nature 20151125 7580

Copy number variations have been frequently associated with developmental delay, intellectual disability and autism spectrum disorders. MECP2 duplication syndrome is one of the most common genomic rearrangements in males and is characterized by autism, intellectual disability, motor dysfunction, anxiety, epilepsy, recurrent respiratory tract infections and early death. The broad range of deficits caused by methyl-CpG-binding protein 2 (MeCP2) overexpression poses a daunting challenge to traditio  ...[more]

Similar Datasets

| GSE71234 | GEO
| GSE71229 | GEO
| PRJNA290638 | ENA
2012-01-08 | E-GEOD-33457 | ArrayExpress
2007-07-17 | E-SMDB-4087 | ArrayExpress
| PRJNA290643 | ENA
2007-08-15 | E-GEOD-8774 | ArrayExpress
2007-08-15 | GSE8774 | GEO
2013-03-12 | E-GEOD-36536 | ArrayExpress
2013-08-02 | E-GEOD-49446 | ArrayExpress